CYTK FY 2016 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$106M+271.3% YoY

Gross Profit

$42M39.5% margin

Operating Income

$19M17.6% margin

Net Income

$16M15.5% margin

EPS (Diluted)

$0.39

Cash Flow

Operating Cash Flow

$37M

Free Cash Flow

$35M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$170M

Total Liabilities

$76M

Stockholders' Equity

$94M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$106M	$29M	+271.3%
Gross Profit	$42M	-$18M	+336.8%
Operating Income	$19M	-$37M	+150.0%
Net Income	$16M	-$38M	+143.9%